Barclays maintains Medpace at equal weight
Barclays maintained its equal-weight rating on Medpace Holdings, according to Benzinga’s ratings-action recap.
Story updates
03:20:50 PM UTC
SquawkNews
Medpace Holdings Price Target Raised to $625.00/Share From $600.00 by Barclays